ORIGINAL RESEARCH
Gene geography of pharmacogenetically significant CYP2C19 cytochrome superfamily DNA markers in the populations of Russia and neighboring countries
1 Research Centre for Medical Genetics, Moscow, Russia
2 Russian Medical Academy of Continuous Professional Education, Moscow, Russia
3 Biobank of North Eurasia, Moscow, Russia
Correspondence should be addressed: Elena V. Balanovska
Moskvorechye, 1, 115522, Moscow, Russia; ur.liam@aksvonalab
Funding: the study was supported by the Russian Science Foundation grant № 21-14-00363 (bioinformatics, statistical and cartographic analysis), State Assignment of the Ministry of Science and Higher Education of the Russian Federation for the Research Centre for Medical Genetics (genealogical analysis, interpretation of the results).
Acknowledgements: the authors would like to thank all sample donors, who took part in the study, and Biobank of North Eurasia for access to DNA collections.
Author contribution: Balanovska EV — data analysis, manuscript writing, research management; Abdulaev ShP — discriptions of pharmacogenetic markers; Gorin IO — bioinformatics analysis; Belov RO — manuscript formatting; Mukatdarova EA — working with genealogical database; Pylev VYu — statistical analysis, cartographic analysis.
Compliance with ethical standards: the study was approved by the Ethics Commitee of the Research Centre for Medical Genetics (protocol № 1 of 29 June 2020); all subjects submitted the informed consent to study participation.